SRPL2023-04-012023-06-30 SRPL2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member SRPL2023-06-30 SRPL2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 123456 SRPL NOTLISTED Shree Ram Proteins Limited Equity 2023-04-01 2024-03-31 2023-08-14 2023-08-05 INR Lakhs First quarter 16:00:00 16:30:00 2023-08-14 2023-08-14 Not applicable Single segment SOLVENT PRODUCT 2023-04-01 2023-06-30 Unaudited Standalone 91053000.00 1024000.00 92077000.00 26790000.00 0.00 44260000.00 2113000.00 10624000.00 2051000.00 3387000.00 89225000.00 2852000.00 0.00 2852000.00 936000.00 -143000.00 793000.00 0.00 2059000.00 0.00 0.00 0.00 0.00 2059000.00 -8000.00 2051000.00 0.00 0.00 214200000.00 1 0.01 0.01 0.00 0.00 0.01 0.01 Notes to the financial results: 1. The Company's Unaudited financial results for the quarter ended June 30, 2023 have been reviewed by the Audit Committee and subsequently approved & taken on record by the Board of Directors of the Company at its meeting held on 14th August, 2023. The Statutory Auditors of the Company have carried out a limited review of these results. 2. The Unaudited financial results for the quarter ended June 30, 2023 have been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards 34 Interim financial Reporting ( Ind AS 34 ) prescribed under section 133 of The Companies Act, 2013 and other recognised accounting practices and the policies to the extend applicable. 3. Rules of previous reporting periods have been regrouped/ reclassified wherever necessary to correspond with the figures of the current reporting period. 4. The Company's Operations fall under a single segment Solvent Products . Hence, segment reporting is not applicable as per Indian Accounting Standard (AS) - 108 Operating Segments. 5. During the quarter ended 30 June 2023, the Company on 19 May 2023( Record Date) ,sub-divided/split of existing Equity Shares of the Company from l(One) Equity Share having face value of Rs.10/-(Rupees Ten Only)each fully paid up ,into 10 (Ten) Equity Share of the face value of Rs.1/- (One) each fully paid up. Accordingly, earnings per share of comparative periods presented has been calculated based on number of shares outstanding in respective periods, as increased by sub-divided/split of shares. 6. The Company is currently in the process of raising additional funds for its business operations. The Company is currently facing a shortage of working capital due to an increase in the working capital cycle of the Company and is in default of its covenants on its bank loans and has not paid various statutory dues to the government. 7. The Corporate Insolvency Resolution Process (CIRP) proceeding has been initiated against the Company by NCL T, Ahmedabad bench with effect from 11.01.2023 under the provision of The Insolvency and Bankruptcy Code, 2016 for non payment of amount to one of the company's creditor. However, stay has been granted by National Company Law Appellate Tribunal Principal Bench, New Delhi, as on 25.01.2023 against above proceeding and ordered to pay amount of Rs. 1,21,82,419/- within two weeks of the order in the name of The Pay and Accounts Officer, Ministry of Corporate Affairs, New Delhi . Other Expenses 3387000.00 Items that will not reclassified to Profit and Loss -11000.00 -11000.00 -3000.00 0.00